Law360 (September 22, 2020, 5:01 PM EDT) -- On Sept. 13, President Donald Trump issued an executive order addressing pricing for drugs covered by Medicare Part B and Part D.
This executive order directs the U.S. Department of Health and Human Services to pursue two rulemakings establishing payment models intended to limit the amount Medicare pays for selected drugs to the lowest price charged for that drug in certain developed economies.
The executive order glosses over the enormous difficulties associated with the restructuring of Medicare Part B and Part D operations in order to implement such models, making it unlikely that a final rule will be issued until after...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!